Legend Biotech Corp LEGN reported downbeat results for the first quarter on Tuesday. The company posted quarterly losses of 3 ...

Legend Biotech (LEGN) stock drew fresh attention after its first quarter 2026 report, with revenue of US$305.1 million, sharply narrower net losses, and strong CARVYKTI sales across an expanded ...

Legend Biotech Corporation Sponsored ADR (LEGN) shares ended the last trading session 18.4% higher at $25.07. The jump came on an impressive volume with a higher-than-average number of shares changing ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Good day, and thank you for standing by. Welcome to the Legend Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's conference is being recorded. I will now hand the ...

View Legend Biotech Corp. Sponsored ADR LEGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Legend Biotech (NASDAQ:LEGN) is one of the most promising mid-cap healthcare stocks under $50. As of December 19 closing, the consensus ratings for Legend Biotech (NASDAQ:LEGN) remain bullish. After a ...

Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting Legend today. From the company, we have Ying Huang, company's CEO.

Legend Biotech Corp (NASDAQ:LEGN) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. In a board shakeup last month, Legend Biotech Corp (NASDAQ:LEGN) appointed chairman and executive ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...